Daniel is passionate about changing the way the world views and treats mental health. As a Clinical psychologist with a BSc in Computer Science, he
has made it his mission to develop innovative solutions to treat mental health across the world. As a result of his ethos, he co-founded Flow Neuroscience, a neurotech company with a focus on empowerment, accessibility and compassion. The first product born from this was Flow, the only medically-certified device to treat Major Depressive Disorder combining brain stimulation with behavioural therapy.
Personally, Daniel wants to normalise conversations towards mental health, inspire young people to innovate and question traditional methods to build more safe and accessible tools.
Flow Neuroscience was founded in 2016 in Malmo, Sweden as the brainchild of clinical psychologist Daniel Mansson and neuroscientist Erik Rehn, to develop revolutionary solutions in the field of mental health. Utilising expertise from psychiatry, brain stimulation, neuroscience and machine learning, Mansson and Rehn had the vision to combine innovation with traditional science and healthcare to empower mental health on a global scale.
Flow is the first solution of the neurotech company and is the only, medically approved at-home brain stimulation treatment for depression. Based on the proven technology of tDCS, the Flow headset alleviates the symptoms of depression on average 30% in 6 weeks* and is combined with a therapy app which empowers and motivates individuals to self-manage their treatment with less severe side effects than alternatives.